Vaishali Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 21.49 | 18.50 | 33.30 |
| Operating Expense | 18.37 | 15.74 | 39.18 |
| Net Profit | 1.97 | 1.70 | -4.68 |
| Net Profit Margin | 9.17 | 9.19 | -14.05 |
| Earning Per Share | 1.51 | 1.48 | -4.37 |
| EBIDTA | 3.13 | 2.77 | -5.83 |
| Effective Tax Rate | 21.09 | 20.58 | 28.74 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 21.49 |
| Operating Expense | 18.37 |
| Net Profit | 1.97 |
| Net Profit Margin | 9.17 |
| Earning Per Share | 1.51 |
| EBIDTA | 3.13 |
| Effective Tax Rate | 21.09 |
Invest in Vaishali Pharma Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 86.28 | 69.66 | 75.82 |
| Operating Expenses Annual | 85.14 | 60.53 | 68.97 |
| Operating Profit Annual | 3.17 | 11.36 | 8.64 |
| Interest Annual | 1.74 | 2.01 | 2.46 |
| Depreciation | 0.38 | 0.40 | 0.33 |
| Net Profit Annual | 0.72 | 6.60 | 4.02 |
| Tax Annual | 0.21 | 2.24 | 1.70 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 86.28 |
| Operating Expenses Annual | 85.14 |
| Operating Profit Annual | 3.17 |
| Interest Annual | 1.74 |
| Depreciation | 0.38 |
| Net Profit Annual | 0.72 |
| Tax Annual | 0.21 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.98 | 1.36 | 0.47 |
| Cash Flow from Operations | 0.81 | 1.08 | 1.32 |
| Cash Flow from Investing | 1.20 | 0.28 | -0.85 |
| Cash Flow from Financing | -1.42 | -1.73 | 0.42 |
| Cash Flow at the End | 1.58 | 0.98 | 1.36 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.98 |
| Cash Flow from Operations | 0.81 |
| Cash Flow from Investing | 1.20 |
| Cash Flow from Financing | -1.42 |
| Cash Flow at the End | 1.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 4.29 | 16.67 | 11.43 |
| PBIT Margin (%) | 3.70 | 15.95 | 10.83 |
| PBT Margin (%) | 2.07 | 8.90 | 6.48 |
| Net PROFIT Margin (%) | 0.83 | 9.47 | 5.30 |
| Return On Networth / Equity (%) | 1.73 | 19.73 | 16.48 |
| Return On Networth /Employed (%) | 5.71 | 21.59 | 18.70 |
| Return On Assets (%) | 1.29 | 12.89 | 9.17 |
| Total Debt / Equity (X) | 0.34 | 0.53 | 0.79 |
| Asset Turnover Ratio (%) | 1.54 | 1.36 | 1.73 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 4.29 |
| PBIT Margin (%) | 3.70 |
| PBT Margin (%) | 2.07 |
| Net PROFIT Margin (%) | 0.83 |
| Return On Networth / Equity (%) | 1.73 |
| Return On Networth /Employed (%) | 5.71 |
| Return On Assets (%) | 1.29 |
| Total Debt / Equity (X) | 0.34 |
| Asset Turnover Ratio (%) | 1.54 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 2.26 | 2.65 | 1.67 |
| Total Current Assets Annual | 74.52 | 72.67 | 76.43 |
| Non Current Assets Annual | 5.44 | 6.23 | 5.20 |
| Total Shareholders Funds Annual | 42.84 | 40.53 | 26.35 |
| Total Assets Annual | 79.96 | 78.90 | 81.62 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 2.26 |
| Total Current Assets Annual | 74.52 |
| Non Current Assets Annual | 5.44 |
| Total Shareholders Funds Annual | 42.84 |
| Total Assets Annual | 79.96 |
No Data Availabe
